Table 19.
Cardiovascular agents.
| N (%) | |
|---|---|
| Alpha-2 Agonist | 148 (28.2) |
| Clonidine | 112 (21.3) |
| Guanfacine | 35 (6.7) |
| Dexmedetomidine | 1 (0.2) |
| Beta-blockers | 132 (25.1) |
| Metoprolol | 48 (9.1) |
| Propranolol | 46 (8.8) |
| Carvedilol | 20 (3.8) |
| Atenolol | 8 (1.5) |
| Labetalol | 5 (1.0) |
| Miscellaneousa | 5 (1) |
| Calcium channel blocker | 87 (16.6) |
| Amlodipine | 54 (10.3) |
| Diltiazem | 16 (3.0) |
| Verapamil | 11 (2.1) |
| Nifedipine | 5 (1.0) |
| Calcium channel blocker unspecified | 1 (0.2) |
| ACEI/ARB | 54 (10.3) |
| Lisinopril | 35 (6.7) |
| Losartan | 12 (2.3) |
| Miscellaneousb | 7 (1.3) |
| Cardiac glycosides | 28 (5.3) |
| Digoxin | 28 (5.3) |
| Other antihypertensives and vasodilators | 25 (4.8) |
| Prazosin | 15 (2.9) |
| Miscellaneousc | 10 (1.9) |
| Antidysrhythmics and other CV agents | 20 (3.8) |
| Cardiovascular agent unspecified | 6 (1.1) |
| Flecainide | 5 (1.0) |
| Miscellaneousd | 9 (1.7) |
| Diuretics | 17 (3.2) |
| Hydrochlorothiazide | 8 (1.5) |
| Furosemide | 5 (1.0) |
| Miscellaneouse | 4 (0.8) |
| Antihyperlipidemic | 14 (2.7) |
| Atorvastatin | 7 (1.3) |
| Miscellaneousf | 7 (1.3) |
| Class total | 525 (100) |
aIncludes nadolol, timolol, nebivolol, and bisoprolol
bIncludes valsartan, benazepril, and enalapril
cIncludes isosorbide, tamsulosin, hydralazine, sacubitril, isobutyl nitrite, and doxazosin
dIncludes amiodarone, midodrine, propafenone, ivabradine, and dofetilide
eIncludes spironolactone, torsemide, and chlorthalidone
fIncludes simvastatin, pravastatin, rosuvastatin, lovastatin, and fenofibrate